Claudio De Nardi

433 total citations
7 papers, 110 citations indexed

About

Claudio De Nardi is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Claudio De Nardi has authored 7 papers receiving a total of 110 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Physiology, 2 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Claudio De Nardi's work include Analytical Chemistry and Chromatography (2 papers), Muscle Physiology and Disorders (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Claudio De Nardi is often cited by papers focused on Analytical Chemistry and Chromatography (2 papers), Muscle Physiology and Disorders (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Claudio De Nardi collaborates with scholars based in Italy, United States and Switzerland. Claudio De Nardi's co-authors include Fabio Bonelli, Georgina Meneses‐Lorente, Alan P. Watt, Timothy Schulz-Utermoehl, Angela Monopoli, Ennio Ongini, Gail D. Thomas, Jianfeng Ye, Ronald G. Victor and Simone Braggio and has published in prestigious journals such as PLoS ONE, Analytical Biochemistry and The FASEB Journal.

In The Last Decade

Claudio De Nardi

7 papers receiving 104 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudio De Nardi Italy 5 51 29 28 19 18 7 110
Laura Tretzel Germany 9 48 0.9× 16 0.6× 77 2.8× 19 1.0× 20 1.1× 12 363
Lisa Broske Italy 5 64 1.3× 38 1.3× 57 2.0× 19 1.0× 39 2.2× 7 170
Carrie Xu United States 9 47 0.9× 80 2.8× 24 0.9× 72 3.8× 18 1.0× 11 290
Anne Rose United States 7 35 0.7× 18 0.6× 14 0.5× 20 1.1× 5 0.3× 11 157
Shengxu Xie China 11 232 4.5× 19 0.7× 15 0.5× 9 0.5× 11 0.6× 27 284
Knut Helkås Dahl Norway 10 168 3.3× 17 0.6× 27 1.0× 10 0.5× 20 1.1× 40 286
Adrien Musuku Belgium 8 35 0.7× 11 0.4× 22 0.8× 38 2.0× 55 3.1× 10 174
Bernice L. Brogdon United States 7 76 1.5× 14 0.5× 88 3.1× 47 2.5× 40 2.2× 9 204
Hoil Kang South Korea 10 92 1.8× 15 0.5× 28 1.0× 69 3.6× 29 1.6× 25 291
Lawrence L. Gan United States 6 29 0.6× 33 1.1× 8 0.3× 15 0.8× 5 0.3× 6 110

Countries citing papers authored by Claudio De Nardi

Since Specialization
Citations

This map shows the geographic impact of Claudio De Nardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio De Nardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio De Nardi more than expected).

Fields of papers citing papers by Claudio De Nardi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio De Nardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio De Nardi. The network helps show where Claudio De Nardi may publish in the future.

Co-authorship network of co-authors of Claudio De Nardi

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio De Nardi. A scholar is included among the top collaborators of Claudio De Nardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio De Nardi. Claudio De Nardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Thomas, Gail D., Jianfeng Ye, Claudio De Nardi, et al.. (2012). Treatment with a Nitric Oxide-Donating NSAID Alleviates Functional Muscle Ischemia in the Mouse Model of Duchenne Muscular Dystrophy. PLoS ONE. 7(11). e49350–e49350. 28 indexed citations
2.
Thomas, Gail D., Angela Monopoli, Claudio De Nardi, Ennio Ongini, & Ronald G. Victor. (2012). Treatment with a nitric oxide‐donating NSAID counteracts functional muscle ischemia in dystrophin‐deficient mdx mice. The FASEB Journal. 26(S1). 1 indexed citations
3.
Rolando, Barbara, Konstantin Chegaev, Loretta Lazzarato, et al.. (2011). Synthesis physicochemical profile and PAMPA study of new NO-donor edaravone co-drugs. Bioorganic & Medicinal Chemistry. 20(2). 841–850. 7 indexed citations
4.
Meneses‐Lorente, Georgina, et al.. (2006). A quantitative high-throughput trapping assay as a measurement of potential for bioactivation. Analytical Biochemistry. 351(2). 266–272. 33 indexed citations
5.
Nardi, Claudio De & Fabio Bonelli. (2006). Moving from fast to ballistic gradient in liquid chromatography/tandem mass spectrometry pharmaceutical bioanalysis: matrix effect and chromatographic evaluations. Rapid Communications in Mass Spectrometry. 20(18). 2709–2716. 31 indexed citations
6.
Nardi, Claudio De, et al.. (2001). Development and validation of a column-switching high-performance liquid chromatographic method for the determination of sanfetrinem in rat and dog plasma by direct injection. Journal of Chromatography B Biomedical Sciences and Applications. 752(1). 133–139. 9 indexed citations
7.
Nardi, Claudio De, Simone Braggio, Luca Ferrari, & Stefano Fontana. (2001). Development and validation of a high-performance liquid chromatography–tandem mass spectrometry assay for the determination of sanfetrinem in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 762(2). 193–201. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026